Etomidate versus Thiopental for Induction of Anesthesia

Authors:
  • JGJeffrey L. Giese
    Jeffrey L. Giese
  • RSRandall J. Stockham
    Randall J. Stockham
  • TSTheodore H. Stanley
    Theodore H. Stanley
  • NPNathan L. Pace
    Nathan L. Pace
  • RNRob H. Nelissen
    Rob H. Nelissen

Abstract
Ate, 0.4 mg/kg, or thiopental, 4 mg/kg), and maintenance anesthetic technique (isoflurane-oxygen, isoflurane-nitrous oxide-oxygen, or fentanyl-nitrous oxide-oxygen). The purpose of this experiment, of factorial design, was to evaluate the combined effects of two or more experimental variables used simultaneously and to observe interaction effects. There were significant increases in heart rate in all groups, especially after tracheal intubation. These increases were attenuated but not eliminated by fentanyl pretreatment. Systolic arterial blood pressure increased significantly after intubation and was not affected either by fentanyl pretreatment or by the induction agent. Patients in whom anesthesia was induced with etomidate had a greater incidence of pain on injection and myoclonus and a lesser incidence of apnea than patients in whom anesthesia was induced with thiopental. Fentanyl pretreatment significantly decreased the incidence of pain on injection and myoclonus, but it increased the incidence of apnea when anesthesia was induced with etomidate. The incidence of postoperative nausea and vomiting was similar after thiopental and etomidate and was unaffected by fentanyl pretreatment. However, patients in whom anesthesia was maintained with isoflurane (with and without nitrous oxide) had a significantly lower incidence of nausea and vomiting than did patients given fentanyl-N2O-O2 for maintenance of anesthesia. These results indicate that there is no significant difference between etomidate and thiopental as anesthetic induction agents in healthy patients. Pretreatment with a small dose of fentanyl attenuates the increases in heart rate associated with induction of anesthesia and tracheal intubation with either etomidate or thiopental, and reduces but does not eliminate side effects associated with etomidate induction. Address correspondence to Dr. Stanley, Professor of Anesthesiology, Department of Anesthesiology, University of Utah Medical Center, 50 North Medical Drive, Salt Lake City, UT 84132. This study was supported in part by grants from Abbott Laboratories, Stanley Research Foundation, and NIH Anesthesia Training Grant #GM07613–05. Accepted for publication March 26, 1985. © 1985 International Anesthesia Research Society...